PT  - JOURNAL ARTICLE
AU  - Arjuna S. Maharaj
AU  - Jennifer Parker
AU  - Jessica P. Hopkins
AU  - Effie Gournis
AU  - Isaac I. Bogoch
AU  - Benjamin Rader
AU  - Christina M. Astley
AU  - Noah Ivers
AU  - Jared B. Hawkins
AU  - Liza Lee
AU  - Ashleigh R. Tuite
AU  - David N. Fisman
AU  - John S. Brownstein
AU  - Lauren Lapointe-Shaw
TI  - Anticipating the curve: can online symptom-based data reflect COVID-19 case activity in Ontario, Canada?
AID  - 10.1101/2021.01.15.21249879
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2021.01.15.21249879
4099  - http://medrxiv.org/content/early/2021/01/15/2021.01.15.21249879.short
4100  - http://medrxiv.org/content/early/2021/01/15/2021.01.15.21249879.full
AB  - Background Limitations in laboratory diagnostic capacity and reporting delays have hampered efforts to mitigate and control the ongoing COVID-19 pandemic globally. Syndromic surveillance of COVID-19 is an important public health tool that can help detect outbreaks, mobilize a rapid response, and thereby reduce morbidity and mortality. The primary objective of this study was to determine whether syndromic surveillance through self-reported COVID-19 symptoms could be a timely proxy for laboratory-confirmed case trends in the Canadian province of Ontario.Methods We retrospectively analyzed self-reported symptoms data collected using an online tool – Outbreaks Near Me (ONM) – from April 20th to Oct 11th, 2020 in Ontario, Canada. We estimated the correlation coefficient between the weekly proportion of respondents reporting a COVID-like illness (CLI) to both the weekly number of PCR-confirmed COVID-19 cases and the percent positivity in the same period for the same week and with a one-week lag.Results There were 314,686 responses from 188,783 unique respondents to the ONM symptom survey. Respondents were more likely to be female and be in the 40-59 age demographic compared to the Ontario general population. There was a strong positive correlation between the weekly number of reported cases in Ontario and the percent of respondents reporting CLI each week (r = 0.89, p <0.01) and with a one-week lag (r = 0.89, p <0.01).Interpretation We demonstrate a strong positive and significant correlation (r = 0.89, p <0.01) between percent of self-reported COVID-like illness and the subsequent week’s COVID-19 cases reported, highlighting that a rise in CLI may precede official statistics by at least 1 week. This demonstrates the utility of syndromic surveillance in predicting near-future disease activity. Digital surveillance systems are low-cost tools that may help measure the burden of COVID-19 in a community if there is under-detection of cases through conventional laboratory diagnostic testing. This additional information can be used to guide a healthcare response and policy decisions.Competing Interest StatementIIB has consulted to BlueDot, a social benefit corporation that tracks the spread of emerging infectious diseases. The authors have no other competing interests to declareFunding StatementThis study is funded by the UofT COVID action initiative (LLS). Outbreaks Near Me is funded by the Center for Disease Control and Prevention, Ending Pandemics and Flu Lab. FluWatchers is funded by the Public Health Agency of Canada.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study was approved by the Ethics Review Board of University Health Network and the University of Toronto and a waiver of informed consent was granted because the data were collected for public health surveillance purposes. All methods were performed in accordance with institutional guidelines and regulations.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData will be made available upon request to the corresponding author